Translation of immunological knowledge into better treatments of chronic hepatitis B.
about
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapyEmerging drugs for hepatitis B.Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B.Effects of telbivudine treatment on the circulating CD4⁺ T-cell subpopulations in chronic hepatitis B patients.Therapeutic vaccination and novel strategies to treat chronic HBV infection.Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection.Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil.Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B.The effect of therapeutic vaccination for the treatment of chronic hepatitis B virus infection.New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response.Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.Human plasmacytoid dendritic cells from patients with chronic hepatitis B virus infection induce the generation of a higher proportion of CD4(+) and CD25(+) regulatory T cells compared with healthy patients.In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
P2860
Q34151071-ADAD962B-5133-4D59-AA77-D4E3775737C0Q35359369-D2C8631C-6656-4C93-A592-CFC9DD658830Q35616664-BF38D177-9558-4AE4-A62E-6C8F8A82B613Q35915060-8B6B5652-544F-491A-B810-01053AD250F1Q37611862-23219850-4A23-463B-ABFB-327F53212AC3Q37723456-B6695AEA-0C16-455D-89A8-56EAB5FC1AFDQ38738345-C9D67D83-DC44-46DD-AF6C-AA7EC8A0B894Q39432561-05BC0594-3A88-45D0-B9A5-0C45540A3E1EQ40370016-A559F837-E6AD-4BCD-855F-3CD0A28B698AQ40761936-9434FBA3-41F7-452E-B41E-4D9D953CF6D9Q41228712-7CA4FD7A-F2DA-470D-BA5B-844C05028F89Q41528269-8956C631-1C84-4673-83CB-F43FEDB07E39Q42099629-4C3CEFFF-AD86-4782-B88F-9E7B53A087EDQ43258398-65A6F72E-A6AE-4F81-8E7E-B7D47334837AQ45399185-3FAB1F53-4C9E-41C5-88B5-845B0EF2815BQ46790482-2B5FA400-69C1-4654-B55D-2679D205B760
P2860
Translation of immunological knowledge into better treatments of chronic hepatitis B.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@ast
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@en
type
label
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@ast
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@en
prefLabel
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@ast
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@en
P1476
Translation of immunological knowledge into better treatments of chronic hepatitis B.
@en
P2093
Nikolai V Naoumov
P304
P356
10.1016/S0168-8278(03)00126-0
P577
2003-07-01T00:00:00Z